• OPEN AN ACCOUNT
Indian Indices
Sensex
77,845.75 -120.60
( -0.15%)
Global Indices
Nasdaq
53,790.86 -21.99
(-0.04%)
Dow Jones
7,769.71 20.51
(0.26%)
Hang Seng
68,341.16 817.10
(1.21%)
Nikkei 225
10,825.49 -18.70
(-0.17%)
Forex
USD-INR
95.38 0.10
(0.10%)
EUR-INR
110.06 0.02
(0.01%)
GBP-INR
128.81 0.17
(0.13%)
JPY-INR
0.60 0.00
(-0.21%)

EQUITY - MARKET SCREENER

Aprameya Engineering Ltd
Industry :  Healthcare
BSE Code
ISIN Demat
Book Value()
77825
INE0LQG01010
36.4170693
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
APRAMEYA
52.92
267.04
EPS(TTM)
Face Value()
Div & Yield %
2.65
10
0
 

InvaGen receives EIR report for its facility in Hauppauge, New York
Aug 04,2026
Cipla announced that its wholly owned subsidiary, InvaGen Pharmaceuticals (InvaGen) has received the Establishment Inspection Report (EIR) from the USFDA, indicating the closure of the inspection of its manufacturing facility located at Hauppauge, Long Island, New York, USA.